Sale!
🔍

Eslicarbazepine Acetate

Original price was: ₹43,000.00.Current price is: ₹42,000.00.

Eslicarbazepine acetate is a prodrug of eslicarbazepine (licarbazepine) which is a metabolite of oxcarbazepine. Eslicarbazepine acetate was recently approved in Europe for the treatment of adjunctive therapy for partial-onset of seizures, with or without secondary generalizations, in adults with epilepsy. 9 The mechanism of its action is the inhibition of voltage gated sodium channels in the brain, making brain cells less prone to excitability. The drug was discovered and developed by Bial, a small privately held Portuguese pharmaceutical company, and is marketed in Europe by Eisai Pharmaceutical Co.

Additional Information:
  • Delivery Time: 1 to 2 days after PO and payment
  • Packaging Details: 25 kg paking
-+
Category:
Get Best Quote

Description

Minimum Order Quantity 25 Kg
Packaging Size 25 KG
Shelf life 3 years
Country of Origin Made in India
Formula C17H16N2O3
Elimination half-life 20 hrs
Protein Binding 30%
Molecular Weight 296.32 g/mol

Our Export Location as a Eslicarbazepine Acetate Manufacturer, Supplier, Exporter, Stockist from India.

Afghanistan

Albania

Algeria

Andorra

Angola

Antigua and Barbuda

Argentina

Armenia

Australia

Austria

Austrian Empire

Azerbaijan

Baden

Bahamas

Bahrain

Bangladesh

Barbados

Bavaria

Belarus

Belgium

Belize

Benin (Dahomey)

Bolivia

Liberia

Libya

Liechtenstein

Lithuania

Luxembourg

Madagascar

Malawi

Malaysia

Maldives

Mali

Malta

Marshall Islands

Mauritania

Mauritius

Mecklenburg-Schwerin

Mecklenburg-Strelitz

Mexico

Micronesia

Moldova

Monaco

Mongolia

Montenegro

 Bosnia and Herzegovina

Botswana

Brazil

Brunei

Brunswick and Lüneburg

Bulgaria

Burkina Faso

Burma

Burundi

Cabo Verde

Cambodia

Cameroon

Canada

Cayman Islands

Central African Republic

Central American Federation

Chad

Chile

China

Colombia

Comoros

Congo Free State

Costa Rica

Morocco

Mozambique

Namibia

Nassau

Nauru

Nepal

Netherlands

New Zealand

Nicaragua

Niger

Nigeria

North German Confederation

North German Union

North Macedonia

Norway

Oldenburg

Oman

Orange Free State

Pakistan

Palau

Panama

Papal States

 Cote d’Ivoire

Croatia

Cuba

Cyprus

Czechia

Czechoslovakia

Democratic Republic of the Congo

Denmark

Djibouti

Dominica

Dominican Republic

Duchy of Parma

East Germany

Ecuador

Egypt

El Salvador

Equatorial Guinea

Eritrea

Estonia

Eswatini

Ethiopia

Federal Government of Germany

Fiji

Papua New Guinea

Paraguay

Peru

Philippines

Piedmont-Sardinia

Poland

Portugal

Qatar

Republic of Genoa*

Republic of Korea (South Korea)

Republic of the Congo

Romania

Russia

Rwanda

Saint Kitts and Nevis

Saint Lucia

Saint Vincent and the Grenadines

Samoa

San Marino

Sao Tome and Principe

Saudi Arabia

 Schaumburg-Lippe*

Finland

France

Gabon

Gambia

Georgia

Germany

Ghana

Grand Duchy of Tuscany

Greece

Grenada

Guatemala

Guinea

Guinea-Bissau

Guyana

Haiti

Hanover

Hanseatic Republics

Hawaii

Hesse

Holy See

Honduras

Hungary

Iceland

Senegal

Serbia

Seychelles

Sierra Leone

Singapore

Slovakia

Slovenia

Solomon Islands

Somalia

South Africa

South Sudan

Spain

Sri Lanka

Sudan

Suriname

Sweden

Switzerland

Syria

Tajikistan

Tanzania

Texas

Thailand

 India

Indonesia

Iran

Iraq

Ireland

Israel

Italy

Jamaica

Japan

Jordan

Kazakhstan

Kenya

Kingdom of Serbia/Yugoslavia

Kiribati

Korea

Kosovo

Kuwait

Kyrgyzstan

Laos

Latvia

Lebanon

Lesotho

Lew Chew (Loochoo)

Timor-Leste

Togo

Tonga

Trinidad and Tobago

Tunisia

Turkey

Turkmenistan

Tuvalu

Two Sicilies*

Uganda

Ukraine

Union of Soviet Socialist Republics*

United Arab Emirates

United Kingdom

Uruguay

Uzbekistan

Vanuatu

Venezuela

Vietnam

Württemberg*

Yemen

Zambia

Zimbabwe

Related products